#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dementia Alzheimer's type Metastatic gastric cancer Frontotemporal dementia Skin angiosarcoma Atypical haemolytic uraemic syndrome Neoplasm Transitional cell carcinoma Castleman's disease Pulmonary tuberculosis Biotinidase deficiency Haemolytic uraemic syndrome Restless legs syndrome Becker's muscular dystrophy Oropharyngeal cancer recurrent Crigler-Najjar syndrome More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma metastatic – Diagnostics Marginal zone lymphoma refractory – Trials in Disease Anaplastic thyroid cancer Mucopolysaccharidosis II – Diagnostics CADASIL – Basic Information Nephrotic syndrome Phenylketonuria – Life with Disease Wolfram syndrome – Trials in Disease Angiosarcoma metastatic – Trials in Disease Langerhans cell sarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Acenocoumarol FIBRIN Doxribtimine Sabatolimab Rp1 Corifollitropin Alfa Altizide Human Serum Albumin Camphor Pegcetacoplan Brigatinib ARLOCABTAGENE AUTOLEUCEL Azelastine Hydrochloride Star-0215 Botulinum Toxin Type A Betaxolol Difelikefalin RO7268489 BROLUCIZUMAB Rifabutin More therapies…

    Learn about Your Condition

    Acute myeloid leukaemia Urethral stenosis Adenocarcinoma pancreas Double hit lymphoma Staphylococcal infection Cholangiosarcoma HER2 positive gastric cancer Apathy Systemic infection Asymptomatic HIV infection Heparin resistance Endometrial cancer Multiple system atrophy Anogenital dysplasia Myocarditis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Sirolimus and Mycophenolate Mofetil for Reducing Hernia Risk in Type 1 Diabetes Patients with End-Stage Kidney Disease Undergoing Pancreas and Kidney Transplantation

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sirolimus
    • Mycophenolate Mofetil
    Czechia

  • Study on Neurodegenerative Diseases Using [18F]RO6958948 for Early Detection and Mapping in At-Risk Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neurodegenerative disorder
    Investigated Drugs:
    • 2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3′,4′-D]Pyrrole
    Sweden

  • Study on Imatinib for Patients with Triple Negative Breast Cancer to Convert it to ER-Positive Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Imatinib
    Sweden

  • Study on the Effectiveness and Safety of Ademetionine with Antidepressants for Patients with Major Depressive Disorder

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ademetionine
    Italy

  • Comparison of dapagliflozin and oral semaglutide effectiveness in type 2 diabetes patients based on insulin resistance or secretion deficit

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Dapagliflozin
    • Insulin Glargine
    • Semaglutide
    Italy

  • Study on Post-Neoadjuvant Therapy for Early Breast Cancer Using Ipatasertib, Inavolisib, and Atezolizumab for Patients with High-Risk Early Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Ipatasertib
    • Pertuzumab
    • Trastuzumab
    Germany
Previous Page
1 … 605 606 607 608 609 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!